Research

Algernon Pharmaceuticals is exploring the little-researched psychedelic substance DMT to see if it has potential in treating stroke patients.

New research is looking at ketamine therapy as a potential aid in slowing the deadly disease ALS, amyotrophic lateral sclerosis.

A new study is looking at how psilocybin treatment may help to reduce debilitating short-lasting unilateral neuralgiform headache attacks.

New research is looking at psilocybin truffles as a potential anti-aging tool and aid in treating age-related psychiatric disorders.

MIcrodosing with psychedelics is gaining in popularity but new research says the placebo effect worked just as well.

NYU will open a $10 million psychedelic research center to further its work in using psychedelic substances to treat mental health issues.

A new study links ketamine therapy to a significant reduction in thoughts of suicide for 69 percent of study participants.

Are the benefits of psychedelic microdosing all in our heads? A new study looks at the results compared to placebo. The results might shock you.

Clinical trials will look at the benefits of 5-MEO DMT as a treatment for relief from a number of mental health issues including depression.